Revenue | ₹456.68Cr |
Net Profits | ₹92.82Cr |
Net Profit Margins | 20.32% |
Anthem Biosciences Ltd’s revenue fell -12.54% since last year same period to ₹456.68Cr in the Q3 2025-2026. On a quarterly growth basis, Anthem Biosciences Ltd has generated -23.67% fall in its revenue since last 3-months.
Anthem Biosciences Ltd’s net profit fell -25.34% since last year same period to ₹92.82Cr in the Q3 2025-2026. On a quarterly growth basis, Anthem Biosciences Ltd has generated -46.48% fall in its net profits since last 3-months.
Anthem Biosciences Ltd’s net profit margin fell -14.64% since last year same period to 20.32% in the Q3 2025-2026. On a quarterly growth basis, Anthem Biosciences Ltd has generated -29.89% fall in its net profit margins since last 3-months.
The revenue for Anthem Biosciences Ltd in the Q3 results 2025 was ₹456.68Cr.
The net profit for Anthem Biosciences Ltd in the Q3 results 2025 was ₹92.82Cr.
The net profit margin for Anthem Biosciences Ltd in the Q3 results 2025 was 20.32%.
The revenue for Anthem Biosciences Ltd in the Q3 results 2024 was ₹522.18Cr.
The net profit for Anthem Biosciences Ltd in the Q3 results 2024 was ₹124.33Cr.
The net profit margin for Anthem Biosciences Ltd in the Q3 results 2024 was 23.81%.